ArticleJournal of orthopaedic surgery and research2026
miR-145-5p combined with miR-140-5p regulates the differentiation of bone marrow mesenchymal stem cells into nucleus pulposus cells and its mechanism in the treatment of intervertebral disc degeneration.
Article in Journal of orthopaedic surgery and research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIntervertebral disc degeneration (IDD) is closely related to the dysfunction of nucleus pulposus cells (NPCs) and the imbalance of their microenvironment. MicroRNAs play a key role in cell differentiation and homeostasis regulation, but the mechanisms underlying the differentiation of bone marrow mesenchymal stem cells (BMSCs) into NPCs are still unclear.
methodsUsing BMSCs and NPCs, this study performed qPCR to measure the expression of miR-140-5p, miR-145-5p, and cartilage-related genes; dual-luciferase reporter assays to verify miR-145-5p targeting SOX9; After inducing BMSC differentiation through miRNA, cell proliferation and migration were analyzed using CCK-8 and Transwell assays, while ELISA and oxidative stress kits were used to detect inflammation factors and oxidative stress levels.
resultsCompared to BMSCs, NPCs exhibited significantly upregulated expression of miR-140-5p, SOX9, COL2A1 and Aggrecan, alongside decreased miR-145-5p levels, reduced ROS and enhanced SOD activity. Mechanistically, SOX9 was confirmed as a direct target of miR-145-5p, while network analysis revealed its functional connection to miR-140-5p targets. Furthermore, dual miRNA modulation synergistically suppressed Notch signaling, promoting the expression of nucleus pulposus-associated markers (KRT19, CA12, HIF-1α), enhancing anabolic genes while suppressing catabolic factors. This coordinated regulation attenuated proliferation and migration while improving oxidative stress and inflammatory microenvironments, collectively promoting chondrogenic differentiation.
conclusionsThe synergistic action of miR-145-5p (via SOX9 targeting) and miR-140-5p promotes BMSC differentiation toward an NPC-like phenotype in vitro, providing mechanistic insight and identifying a potential therapeutic target for disc degeneration that requires future in vivo validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.